Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/11283131

J. Clin. Oncol. 2001 Apr 1 19 7 1985-92

Download in:

View as

Triples

General Info

PMID
11283131